Medibank share price remains suspended amid worsening cyber incident

Medibank dropped another bombshell this morning…

| More on:
A woman sits with her hands covering her eyes while lifting her spectacles sitting at a computer on a desk in an office setting.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Medibank shares remain suspended from trade
  • This morning the company advised that Medibank customer data was also stolen
  • Management doesn't know how much data was taken

The Medibank Private Ltd (ASX: MPL) share price remains suspended from trade on Tuesday.

But that hasn't stopped the embattled private health insurer from releasing another cyber-attack update to the market this morning.

Unfortunately, things continue to go from bad to worse for the company.

What's the latest?

Incredibly, it seems that every few days the Medibank cyber-attack incident escalates further.

Originally, the company believed that it had foiled a ransomware attack and advised that there was no evidence that data was taken from its systems. However, it was soon contacted by hackers informing it that data was taken and demanding a ransom.

At that point, the company believed that only its AHM and international student businesses had been impacted by the cyber-attack.

But that no longer remains the case. This morning the company advised that the hackers have "taken data that now includes Medibank customer data, in addition to that of ahm and international student customers."

Worryingly, once again, Medibank was unable to see that its data had been stolen and the hacker had to produce a sample file to show that this was the case.

In light of this, the company advised that it is unable to say just how much data has been taken that could ultimately be leaked to the world. It commented:

Given the complexity of what we have received, it is too soon to determine the full extent of the customer data that has been stolen. We will continue to analyse what we have received to understand the total number of customers impacted, and specifically which information has been stolen. We have taken the step of making this announcement as we believe it is important to notify our customers of this development. As we continue to investigate the scale of this cybercrime, we expect the number of affected customers to grow as this unfolds.

Premium increases on hold

Perhaps in an effort to stop customers churning to another provider, the company has decided to postpone its premium increases for Medibank and AHM customers until 16 January 2023.

In addition, Medibank's CEO, David Koczkar, once again apologised for the incident. He said:

I unreservedly apologise to our customers who have been the victims of this serious crime. As we continue to uncover the breadth and gravity of this crime, we recognise that these developments will be distressing for our customers, our people and the community – as it is to me. This is a malicious attack that has been committed by criminals with a view of causing maximum fear and damage, especially to the most vulnerable members of our community. We continue to work closely with the agencies of the Federal Government, including the ongoing criminal investigation into this matter. We thank them for their ongoing support and assistance.

When will the Medibank share price return to trade?

As things stand, the Medibank share price is scheduled to return to trade on Wednesday.

However, given the state of things, it seems quite likely that the company will push back its return date until things are resolved.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

drug capsule opening up to reveal dollar signs signifying rising asx share price
Healthcare Shares

3 ASX healthcare shares going gangbusters on Thursday

Investors are sending these ASX healthcare stocks soaring today. But why?

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Is it time to cash in on Sigma shares?

Shares have extended after the Chemist Warehouse merger.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Healthcare Shares

Buy this ASX 200 share that is swimming in cash

Bell Potter sees potentially big returns on offer from this cashed-up stock.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Are CSL shares a buy after the biotech's FY25 forecasts?

Brokers continue to weigh in.

Read more »

Female pharmacist smiles with a digital tablet.
Healthcare Shares

Are Wesfarmers or Sigma shares a better buy in the pharmacy arena?

These two stocks are both leaders in the industry.

Read more »

A young man goes over his finances and investment portfolio at home.
Healthcare Shares

Down 20%, is the NIB share price undervalued?

Here's what Goldman Sachs is saying about this blue chip stock.

Read more »

four excited doctors with their hands in the air
Healthcare Shares

Sigma Healthcare shares rocket 39% on Chemist Warehouse merger approval

The ACCC doesn't believe the company's merger with Chemist Warehouse will lessen competition.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

ASX 200 healthcare stock rockets on $75 million news

This marks another positive step for the company.

Read more »